Home » Topics » BioWorld Science

BioWorld Science
RSS

Transgenic CYP2C19 mouse as a new animal model for hyperdopaminergism-induced hyperkinesia

Sep. 12, 2019

NEK7 identified as potential biomarker associated with obsessive compulsive disorder

Sep. 12, 2019

S100-B found to be a peripheral biomarker for estimating addiction treatment efficacy

Sep. 12, 2019

ANKRD12 as a novel biomarker in schizophrenia and bipolar disorder

Sep. 12, 2019

Positive CTC data from phase II TYME-88-PANC study of SM-88

Sep. 12, 2019

Tiziana presents phase I results for nasal foralumab

Sep. 12, 2019

Molecular Partners initiates first-in-human study of MP-0310

Sep. 12, 2019

Murine model reveals TRPA1 loss is involved in age-related dilated cardiomyopathy

Sep. 12, 2019

Pfizer reports preliminary data from phase II pediatric study of 20vPnC candidate

Sep. 10, 2019

Translate Bio discontinues MRT-5201 for OTC deficiency, prioritizes pulmonary disease programs

Sep. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...